Observational studyFrontiers in endocrinology2025
Frozen-thawed double cleavage-stage or frozen-thawed single day 6 blastocyst stage embryo transfer: which is preferable for patients younger than 35 without day 5 blastocyst formation?
Observational study in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of intrauterine infusion of human umbilical cord blood mononuclear cells on reproductive outcomes in patients with thin endometrium undergoing frozen embryo transfer.Frontiers in cell and developmental biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To compare the clinical outcomes between frozen-thawed cleavage embryo transfer and frozen-thawed day 6 blastocyst transfer in patients younger than 35 using the freeze-all strategy without day 5 blastocyst formation. Methods: This was a retrospective observational analysis performed between January 2018 and December 2022 at the Reproductive and Genetic Specialist Hospital of the First Affiliated Hospital of Zhengzhou University. A total of 576 patients younger than 35 who used the "freeze-all strategy" but produced no day 5 blastocysts were recruited. The patients were divided into 3 groups according to the number and stage of the transferred embryos: double cleavage-stage embryos (Group A), single good-quality day 6 blastocysts (Group B) and single inferior-quality day 6 blastocysts (Group C),and several pregnancy outcomes were measured. Results: Groups A and B exhibited significantly higher chemical (73.7%, 67.0% versus 51.9%) and clinical pregnancy rates (69.0%, 59.4% versus 44.2%) than Group C. The implantation rate was significantly higher in Group B than in Groups A and C (59.4% versus 45.7%, 43.5%). The live birth rate was significantly higher in Group A than in Group C (59.2% versus 48.1%). The multiple pregnancy rate was significantly higher in Group A than in Groups B and C (34.4% versus 1.6%, 1.5%). The early miscarriage rate was significantly higher in Group C than in Group A and Group B (23.5% versus 8.7%, 12.7%). Premature delivery rates, late miscarriage rates and ectopic pregnancy rates were comparable across groups. Conclusions: A single good quality day 6 blastocyst transfer was the preferable strategy for the freeze-all strategy patients who younger than 35 and without day 5 blastocyst formation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.